Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

CXC chemokine receptor 4 (CXCR4) targeted gold nanoparticles potently enhance radiotherapy outcomes in breast cancer

Nanoscale(2021)10.1039/d1nr05385jSource: DataRank Database

CXC chemokine receptor 4 (CXCR4) targeted gold nanoparticles potently enhance radiotherapy outcomes in breast cancer is a research paper published in Nanoscale (2021). On theSindex it has a DataRank of 0. It has been cited 21 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access21 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.81)OA: greenTopics (40)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Yuri Mackeyev ORCID,Bhanu Prasad Venkatesulu ORCID,Sunil Krishnan ORCID,Pankaj K. Singh ORCID,Shanta Bhattarai

Live enrichment

PubMed:34757363 PMC:PMC9124374 OpenAlex:https://openalex.org/W3205736542

National Cancer Institute

Grant: P30 CA16672

NIDCR NIH HHS

Grant: R01 DE028105

NCI NIH HHS

Grant: R01 CA155446

NCI NIH HHS

Grant: P30 CA016672

NCI NIH HHS

Grant: R01 CA257241

FWCI

0.81

Citation Percentile

0.7%

Citation Trend

2022

2023

2024

2025

2026

greenLicense: http://rsc.li/journals-terms-of-use

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9124374

publisherhttp://pubs.rsc.org/en/content/articlepdf/2021/NR/D1NR05385J

journalhttps://doi.org/10.1039/d1nr05385j

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34757363

Fields of Study

Immunotherapy and Immune ResponsesCancer Cells and MetastasisChemokine receptors and signalingAnimalsBreast NeoplasmsCell Line, TumorFemaleGoldHumansMetal NanoparticlesMiceReceptors, CXCR4Triple Negative Breast NeoplasmsXenograft Model Antitumor Assays

MeSH Terms

AnimalsBreast NeoplasmsFemaleGoldHumansReceptors, CXCR4Xenograft Model Antitumor AssaysCell Line, TumorMiceMetal NanoparticlesTriple Negative Breast Neoplasms

Keywords

CXC chemokine receptorsBreast cancerCXCR4Colloidal goldChemokine receptorMedicineCancer researchOncologyChemokineInternal medicineReceptorCancerMaterials scienceNanoparticleNanotechnology

Sustainable Development Goals

SDG 0: Good health and well-being